JCI Insight is a peer-reviewed journal dedicated to biomedical research, ranging from preclinical to clinical studies.
JCI Insight publishes well-executed, high-quality, insightful research in all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.
Papers submitted to JCI Insight should present a focused line of investigation that provides meaningful and impactful contributions to the understanding of the biology of disease or new therapeutic opportunities. JCI Insight articles may build on existing paradigms in the field or provide hypothesis-generating findings. Examples of studies suitable for JCI Insight include, but are not limited to, human genetics research, new mouse models of disease, in vivo studies of disease mechanisms, precision medicine, clinical and biomarker studies, and studies that provide new resources for the biomedical research community. Studies should include a relevant in vivo model system and/or a primary human cell or tissue model.
JCI Insight builds on the editorial leadership of the JCI, one of the oldest and most respected biomedical research journals, and is published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists incorporated in 1908. JCI Insight serves to fulfill the ASCI’s objective to advance medical science through the publication of clinically relevant research reports. All articles published in JCI Insight are freely available online from the moment of publication.
The focus of JCR: Journal of Clinical Rheumatology; is on practice-related issues of rheumatic and musculoskeletal diseases. In original reports and reviews, physicians will find expert insights on the first and second line treatments. Other regular features include quick-reading mini-reviews, radiographic case discussions, and critiques of new and coming treatments. A multidisciplinary international editorial board provides readers with authoritative worldwide coverage from well-known experts on the science and practice of rheumatology.
• Open access and freely available to all readers
• Fully citable through Digital Object Identifiers (DOI)
• Rapidly available online via Science Direct, the world's largest online journal platform, or at
•
Like the journal,